Skip to content

Structure Therapeutics Inc.

GPCR

CIK 0001888886 · Pharmaceutical Preparations · Nasdaq

  • ShouTi Inc. (until 2022-05-13)
← back to feed
Revenue (TTM)
—
Q1 Apr 2026
Net Income (TTM)
−$250.17M
−15.2% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$1.19
−2.6% YoY Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
—
Q1 Apr 2026
Net Margin
—
Q1 Apr 2026
Free Cash Flow (TTM)
−$93.11M
Q1 Apr 2026
Cash
$316.17M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
213.22M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings